BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9310493)

  • 1. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
    Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
    Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
    Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia.
    Inaba T; Shimazaki C; Sumikuma T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Kobayashi Y; Rin K; Murakami S; Haruyama H; Fujita N; Nakagawa M
    Leuk Res; 2001 Feb; 25(2):109-13. PubMed ID: 11166825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
    Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
    Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor.
    Ino T; Tsuzuki M; Okamoto M; Shamoto M; Hirano M
    Ann Hematol; 1999 Jan; 78(1):43-7. PubMed ID: 10037270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
    Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
    Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
    Miller JS; Verfaillie C; McGlave P
    Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.